December 12, 2013 – Atlanta, GA – HealthStat Rx puts its leading medication therapy management program to work for millions of Hepatitis C (HCV) patients nationwide to leverage the latest treatments with cure rates up to 90 percentOne of the nation’s leading medication therapy management companies, HealthStat Rx, announces today it offers Sovaldi™ from Gilead Sciences and Olysio™ from Janssen Therapeutics, to treat chronic hepatitis Cvirus (HCV) infection in adults.

“FDA studies indicate that the latest HCV treatments, Sovaldi and Olysio, used in conjunction with other antiviral medications, result in cure rates of up to 90 percent after 12 weeks of therapy for patients in certain genotypes,” says Vickie Andros, Director of Clinical Services at HealthStat Rx. “What’s critical about these HCV cures is that they require careful management of medication delivery to be effective,” she says. “That’s where HealthStat Rx stands out. Our innovative medication management methodology, with our clinically proven success in working with virology patients, is the perfect complement to physicians and healthcare networks that demand HCV success for their patients.”

HealthStat Rx’s national customer base includes hospitals, clinics, healthcare networks, home health care providers and patients with chronic disease. HealthStat Rx partners with patients and providers to drive superior outcomes. A 2013 medication adherence comparison study showed HealthStat Rx patients had a 35 percent higher adherence rate than that of similar study patients receiving their medications from a retail pharmacy chain. Another recent national study showed patients enrolled in HealthStat Rx’s medication therapy management program benefitted from a 60 percent decrease in hospital re-admissions.

“We are excited to be part of this cure and look forward to partnering with doctors and patients who aim to attain optimal cure rates through perfect medication adherence,” says Patrick Dunham, HealthStat Rx CEO.

Founded in 2000, HealthStat Rx has evolved into an integral partner in medication and care management for healthcare networks, hospitals, clinics and patients. The company provides services nationwide that maximize its successful medication management methods for numerous chronic diseases including HCV, HIV, diabetes and heart disease.

About HealthStat Rx

HealthStat Rx treats patients nationwide through its medication management protocols, including medication reconciliation and establishment of personalized medication regimens, and supports its provider partners and care coordination with its award-winning EMR, MedPlan™. HealthStat Rx’s healthcare professionals provide individualized care proven to improve the lives of chronically ill patients.